Back to Directory
Apini Therapeutics
Founded 2021
Small-molecule treatments for chronic inflammatory diseases
Apini Therapeutics is a biotechnology company developing small-molecule treatments for chronic inflammatory diseases. Its programme targets the inflammatory activity of extracellular nicotinamide phosphoribosyltransferase, known as eNAMPT, with potential applications in inflammatory bowel disease and other disorders. A University of Manchester spinout, Apini builds on research conducted with King’s College London and advances its compounds with scientific and operational support from Slingshot Therapeutics.